Absence of inspiratory laryngeal constrictor muscle activity during nasal neurally adjusted ventilatory assist in newborn lambs by Hadj-Ahmed, Mohamed Amine et al.
ABSENCE OF INSPIRATORY LARYNGEAL CONSTRICTOR MUSCLE 
ACTIVITY DURING NASAL NEURALLY ADJUSTED VENTILATORY 
ASSIST IN NEWBORN LAMBS 
 
Mohamed Amine Hadj-Ahmed†, Nathalie Samson†, Jennifer Beck*, Jean-Paul Praud† 
 
† Neonatal Respiratory Research Unit, Departments of Pediatrics and Physiology, 
Université de Sherbrooke, QC, Canada, J1H 5N4 
* Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's 
Hospital, Toronto, Ontario, M5B 1W8 Canada and Department of Pediatrics, University 
of Toronto, Canada 
 
 
Short title: Laryngeal closure and neurally adjusted ventilator assist 
 
 
Address for correspondence and proofs: 
Jean-Paul Praud MD PhD  
Departments of Pediatrics and Physiology 
Université de Sherbrooke 
J1H 5N4, QC Canada 
Tel: (819) 346-1110, ext 14851 
Fax: (819) 564-5215 
email: Jean-Paul.Praud@Usherbrooke.ca 
1 
 
ABSTRACT 
It has been demonstrated that a progressive increase in nasal pressure support 
ventilation (nPSV) leads to an active inspiratory glottal closure in non-sedated newborn 
lambs, which limits lung ventilation (24, 33). Unlike nPSV, the pressure delivered during 
nasal Neurally Adjusted Ventilatory Assist (nNAVA) is synchronized to the diaphragm 
electrical activity on inspiration (36). Given the tight neural integration of the glottal 
dilators and constrictors with diaphragm activity on inspiration and expiration 
respectively, the aim of the present study was to test the hypothesis that inspiratory 
glottal closure does not develop during nNAVA. Polysomnographic recordings were 
performed in eight non-sedated, chronically instrumented lambs, which were ventilated 
with progressively increasing levels of nPSV and nNAVA, in random order. States of 
alertness, diaphragm and glottal muscle electrical activity, tracheal pressure, SpO2, 
tracheal PETCO2 and respiratory inductive plethysmography were continuously recorded. 
While phasic inspiratory glottal constrictor electrical activity appeared with increasing 
levels of nPSV in 5 out of 8 lambs, it was never observed at any nNAVA level in any 
lamb, even at maximal achievable nNAVA levels. In addition, a decrease in arterial 
PCO2 was neither necessary nor sufficient for the development of phasic inspiratory 
glottal constrictor activity. In conclusion, nNAVA does not induce active glottal closure in 
non-sedated newborn lambs at high-pressure levels, in contrast to nPSV. 
KEYWORDS: Nasal intermittent positive pressure ventilation, diaphragm electrical 
activity, pressure support ventilation, thyroarytenoid muscle, glottis, quiet sleep. 
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INTRODUCTION 
Nasal intermittent positive pressure ventilation (nIPPV) is increasingly used for treating 
acute respiratory distress in lieu of endotracheal IPPV, including in infants (23). The use 
of nIPPV is aimed at preventing the severe complications related to the presence of an 
endotracheal tube, such as pulmonary infections, tracheal bleeding, tracheal granuloma 
and subglottic stenosis (23, 28). Common indications for nIPPV in infants include 
respiratory distress syndrome, weaning from endotracheal ventilation, treatment of 
chronic lung disease, severe apneas of prematurity and respiratory syncytial virus 
infection (3, 15, 19, 23, 31). 
However, an important difference using a nasal interface as opposed to an endotracheal 
tube for mechanical ventilation is the interposition of the laryngeal valve between the 
ventilator and the lungs. Recently, we have shown that increasing the level of nIPPV in 
newborn lambs induces an active laryngeal narrowing during inspiration with increased 
laryngeal resistance opposing ventilator insufflations (24). Further experiments showed 
that this reflex laryngeal narrowing mainly originates from the lower airways and is 
vagally mediated (33). The potential clinical importance of these observations is related 
to the fact that active laryngeal narrowing restricts lung ventilation and diverts air 
towards the digestive system during insufflation, thereby exposing the infant to gastric 
distension and further respiratory compromise (16, 21). 
Our previous results on nIPPV were obtained both with volume-controlled ventilation and 
pressure support ventilation (PSV). Despite the fact that these modes are routinely used 
for both invasive and non-invasive ventilation in intensive care units, major asynchronies 
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between the ventilator and the patient can occur, both in terms of the timing and level of 
assist provided (1, 10, 11, 13, 14, 27).  
Neurally-adjusted ventilatory assist (NAVA) largely overcomes difficulties encountered 
with the usual assisted ventilation modes by providing a more physiological ventilatory 
assistance to patients (36). This is mainly because of its unique paradigm, where the 
electrical activity (EA) of the diaphragm (EAdi) triggers and cycles off the ventilator, 
thereby improving patient-ventilator interaction (1, 10, 11, 13, 14, 27). In addition, the 
automatic adaptation of the strength of the insufflation upon the level of EAdi throughout 
each inspiration in NAVA ensures a tailored inspiratory support (36). Thus, down-
regulation of the EAdi with increasing assist prevents over-assist by the ventilator, and 
studies have shown that, unlike PSV, it is not possible to hyperventilate with NAVA to 
the point of diaphragm inactivity (20). Also, when used for non-invasive ventilation, the 
neural trigger used during nNAVA is largely unaffected by leaks, contrary to all other 
non-invasive ventilation modes, including PSV, which are flow- or pressure-triggered (8, 
9). Finally, the close neural integration between the timing of upper airway dilators and 
diaphragm inspiratory EA (17, 35), together with NAVA’s unique characteristics, make 
this mode an attractive option, especially for nasal, non-invasive ventilation, including in 
the newborn. 
The main objective of this study was to test the hypothesis that the more physiological 
approach taken to assist ventilation in nNAVA prevents the development of inspiratory 
activity of laryngeal constrictor muscle, contrary to nPSV, in non-sedated, chronically 
instrumented newborn lambs. In addition, because over-assist and hypocapnia are 
much more likely to develop with nPSV than nNAVA, a secondary aim of the study was 
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to test whether hypocapnia is involved in the development of inspiratory laryngeal 
narrowing observed in PSV. 
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MATERIAL AND METHODS 
 
Animals 
Experiments were conducted in eight mixed-bred term lambs aged from 4 to 9 days and 
weighing 4.2 kg (SD 0.8; range 2.66 – 5.52 kg). The study was approved by the ethics 
committee for animal care and experimentation of the Université de Sherbrooke. All 
lambs were housed with their mother in our animal quarters. 
 
Surgical instrumentation 
Aseptic surgery was performed in all lambs at 2 days of life, under general anesthesia 
(1-2% isoflurane + 30 % N2O + balance O2), after an intramuscular injection of atropine 
sulfate (0.1 mg/kg), ketamine (10 mg/kg) and morphine (25 µg /kg) and an intravenous 
bolus (10 ml/kg) of Ringer’s lactate solution. One dose of ketoprofen (3 mg/kg) was also 
injected intramuscularly for analgesia and repeated if needed 12h later. Antibiotics (5 
mg/kg gentamicin and 0.05 ml/kg duplocilline) were administered intramuscularly prior to 
surgery and daily thereafter. Chronic instrumentation was performed as described 
previously (12). Briefly, custom-made bipolar gold electrodes were inserted into both 
thyroarytenoid muscles (ta, a laryngeal constrictor) and cricothyroid muscles (ct, a 
laryngeal dilator) for EAta and EAct recordings. Two needle electrodes were inserted 
into the parietal cortex directly through the skull for electrocorticogram (ECoG), with a 
third needle electrode inserted under the scalp as a ground. Two custom-made silver 
electrodes were inserted subcutaneously close to the right eye socket for 
electrooculogram (EOG) recordings. A catheter was inserted into the right carotid artery 
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for blood sampling and gas analysis. In addition, two custom-made catheters were 
installed between the third and fourth and the fifth and sixth tracheal rings in order to 
record tracheal pressure and end tidal CO2 (PetCO2). Finally, a 20 Fr voice prosthesis 
(Blom-Singer Advantage, InHealth Technologies, Carpinteria, CA, USA) was placed 
between the cervical esophagus and the skin to allow a one-way access to the 
esophagus in order to insert a catheter for recording EAdi (see below). Post-operative 
care included daily temperature and weight monitoring, as well as daily flush of the 
arterial catheter with heparin solution. Lambs were euthanized at the end of experiments 
by pentobarbital overdose. Correct electrodes positioning was systematically verified at 
necropsy. 
 
Recording equipment 
Polysomnographic recordings (figure 1) were obtained by using our custom-built 
radiotelemetry system with channels for ECoG, EOG and muscle EA (22). The raw 
signals were sampled at 1000 Hz, rectified and moving-time averaged at 100 ms. 
Thoracic and abdominal volume variations were qualitatively assessed using respiratory 
inductance plethysmography (Ambulatory Monitoring, Ardsley, NY, USA). Airflow was 
collected using a pneumotachograph (21070B + 47304A flow transducer, Hewlett 
Packard, Palo Alto, CA, USA) attached to the nasal mask. A pulse oximeter sensor 
(LNOP YI reflectance sensor, Masimo, Irvine, CA, USA) was attached at the base of the 
tail for continuous monitoring of arterial hemoglobin saturation (SpO2) and pulse wave. 
Mask pressure (Pmask, a measure of the level of ventilator support) and tracheal 
pressure (Ptrach, a measure of the ventilator support reaching the lower airways) were 
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continuously recorded using two pressure transducers (TSD160A, Biopac Systems, 
Santa Barbara, CA, USA). PetCO2 was recorded using a CO2 analyzer (Capnogard®, 
Model 1265, Respironics, Inc., California, USA).  
An 8Fr “NAVA catheter” was inserted into the esophagus through the voice prosthesis 
down to the level of the crural diaphragm as previously described (4, 8). This catheter 
contains an array of miniaturized sensors for measurement of the EAdi waveform (2). A 
dedicated window for verifying electrode positioning was consulted throughout the 
protocol (7). 
All parameters were continuously recorded using AcqKnowledge software (version 4.1, 
Biopac Systems, Santa Barbara, CA, USA). In addition, an observer was continuously 
present to note all events occurring during recordings. Finally, arterial blood gases were 
determined using a blood gas analyzer (GEM Premier 3000 PAK, Instrumentation 
Laboratory, Lexington, MA, USA) and systematically corrected for rectal temperature of 
the lamb (5). 
 
Ventilatory equipment 
Nasal pressure support ventilation (nPSV) and neurally-adjusted ventilatory assist 
(nNAVA) were performed using a Servo-i Ventilator (Maquet Critical Care®, Solna, 
Sweden) with heated (33oC) and humidified air. Nasal PSV was triggered by flow. The 
muzzle of each lamb was fitted with a nasal mask custom-built from a plaster shell filled 
with dental paste, as previously described (34).  
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Design of study 
All lambs were housed with their mother in our animal quarters until the experimental 
day. Following a postoperative recovery period of 48 hours, polysomnographic 
recordings were performed without sedation, while lambs were comfortably positioned in 
a sling with loose restraints. Following a first recording with the nasal mask only (i.e. no 
ventilatory support), a nasal CPAP of 4 cmH2O was applied for the second recording. 
Nasal PSV and NAVA were then tested in all lambs in random order, while maintaining a 
positive end expiratory pressure (PEEP) at 4 cmH2O. In the PSV mode, three different 
levels of pressure support were successively studied, namely 6, 11 and 16 cmH2O (= 
peak inspiratory pressure of 10, 15 and 20 cmH2O) (24, 33). In the NAVA mode, 3 
levels, arbitrarily called NAVA levels 1 and 2 and NAVA max, were determined in each 
lamb as follows. NAVA level 1 corresponded to the proportionality factor, which resulted 
in a peak inspiratory pressure close to 10 cmH2O, i.e., matching the first PSV level. 
Similarly, NAVA level 2 corresponded to a peak inspiratory pressure close to 15 cmH2O, 
while NAVA max was the maximum achievable level of NAVA in the lamb under study. 
We aimed at recording at least 5 minutes of quiet sleep (QS) for each condition 
(Baseline, CPAP, all nPSV levels and all nNAVA levels). The potential involvement of 
hypocapnia in the development of active glottal closure with nPSV or nNAVA during QS 
was assessed as follows. First, PetCO2 was measured from the dedicated tracheal 
sampling catheter. Because of technical constraints (condensation in the sampling 
catheter after more than 1-min recording), PetCO2 was recorded during the last minute 
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of each ventilatory level. In addition, PaCO2, PaO2 and pH were measured on arterial 
blood sampled at the end of each ventilatory level. 
 
Data analysis 
States of alertness: Standard electrophysiological and behavioral criteria were used to 
recognize QS from wakefulness and active sleep (32). Only periods of established QS 
were analyzed. 
Respiratory variables 
At each ventilatory level, the first 60 seconds of continuous QS were selected for 
analysis. Respiratory rate (RR) was calculated from the airflow wave obtained with the 
pneumotachograph, as well as from the mask pressure and the sum signal of the 
respiratory inductance plethysmography. Expiratory tidal volume (VT, ml/kg) was 
measured by integration of airflow using a Hewlett-Packard 21070–60040 
pneumotachograph interposed between the ventilator and nasal mask. 
In addition, breath-by-breath analysis was performed on the EAdi waveform. As 
described previously (10), three time cursors were placed for each breath on the 
displayed EAdi waveform: (i) onset of inspiratory EAdi signal, (ii) peak of EAdi, and (iii) 
onset of next inspiratory EAdi signal. The period from onset to peak EAdi signal was 
identified as the neural inspiratory time and used to calculate the peak phasic EAdi 
during inspiration. The period from peak EAdi to the onset of the next inspiratory EAdi 
signal was identified as the neural expiration time. Neural respiratory rate was calculated 
using the above identified neural inspiratory and expiratory times. The EAdi-time product 
(an indication of diaphragm energy expenditure) was calculated per minute as the 
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product of the mean inspiratory phasic EAdi, the neural inspiratory time and the neural 
respiratory rate (10). Values were averaged for 60 seconds. 
The percentage of respiratory cycles with inspiratory phasic EAta (%inspirEAta) was 
calculated. In addition, the mean amplitude of phasic inspiratory EAta (ampliEAta) was 
determined and expressed in proportion to the maximum EAta amplitude (averaged 
during 4 swallows in each lamb). Similarly, the percentage of respiratory cycles with 
phasic inspiratory EAct (%inspirEAct) was calculated, as well as the mean amplitude of 
phasic inspiratory EAct (ampliEAct), expressed in proportion to the averaged EAct 
during CPAP 0 recording. Finally, PetCO2 was measured during the last minute of the 
recording at each ventilatory level. PaCO2, PaO2 and pH were measured on arterial 
blood sampled at the end of each ventilatory level.  
 
Statistical analysis 
All variables (RR, VT, PetCO2, PaCO2, PaO2, pH, EAdi-time product, %inspirEAta, 
ampliEAta, %inspirEAct, ampliEAct) were expressed as mean (SD). Statistical analyses 
were performed on raw data for all variables. Normality was first systematically tested 
using the Shapiro-Wilk test and histogram distribution of the data. The first set of 
analyses tested the effect of the mode and level of ventilation (independent variables). 
Blood gases, respiratory rate and PetCO2 (normal distribution) were analyzed through a 
general linear model two-way ANOVA for repeated measures using PROC MIXED of 
SAS software (version 9.1.3). The remaining variables, namely pH, VT, EAdi-time 
product, %inspirEAta and %inspirEAct, ampliEAta and ampliEAct (not normally 
distributed) were analyzed with Friedman’s test followed by the post-hoc Wilcoxon 
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signed rank test using SPSS (SPSS statistics 17.0). Secondly, a regression analysis 
was performed to test the relationship between %inspirEAta or ampliEAta and PaCO2 or 
PetCO2 using PROC GENMOD of SAS. Differences were considered significant if P < 
0.05. In addition, given the relatively small number of studied lambs, a P < 0.1, indicative 
of a tendency towards a significant difference, was fully considered in the discussion of 
the results. 
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RESULTS 
 
Experiments were completed in 8 newborn term lambs without sedation (age: 5 ± 2 
days; weight: 4.2 ± 0.9 kg). Examples of recordings obtained for muscle activities at PSV 
20/4 and NAVA max and for pressures applied from CPAP 0 to PSV 20/4 and to NAVA 
max are given in figures 2 and 3 respectively. 
 
Ventilatory variables 
A progressive decrease in RR was observed with increasing nPSV as well as nNAVA 
level (Table 1). Overall, a 44% and 38% decrease in RR was observed respectively with 
PSV 20/4 (P = 0.0002) and NAVA max (P = 0.001), as compared to CPAP 4. RR at PSV 
20/4 was not different from RR at NAVA max. Simultaneously, VT increased with both 
nPSV and nNAVA (figure 4), the value observed with nNAVA max being comparable to 
the value observed with nPSV 15/4. 
While arterial blood gas values could be obtained in 7 of 8 lambs studied, PetCO2 was 
recorded in all 8 lambs (Table 1). Overall, a significant decrease in both PaCO2 (P = 
0.02) and PetCO2 (P < 0.0001) was progressively observed with increasing levels of 
PSV. Simultaneously, a tendency towards a decrease in PetCO2 was only observed 
between CPAP 4 and NAVA max (P = 0.06). In addition, both PaCO2 (P = 0.04) and 
PetCO2 (P = 0.0007) were significantly lower at PSV 20/4 than NAVA max. An overall 
significant increase in pH (P = 0.03) was only observed in PSV. Finally, no significant 
changes in PaO2 were observed with either increasing PSV or NAVA modes.  
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A significant decrease in EAdi-time product was observed with increasing nNAVA level 
(p = 0.02). With increasing PSV level, the EAdi-time product decreased significantly at 
both PSV 15/4 (P = 0.04) and PSV 20/4 (P = 0.05) compared to CPAP 4. In addition, 
EAdi-time product tended to be lower at PSV 20/4 than at NAVA max (p = 0.08) (figure 
4).  
 
Inspiratory active laryngeal closure during nasal ventilation 
Overall, while phasic inspiratory EAta (glottal constrictor activity) appeared with 
increasing PSV in 5 of 8 lambs, it was never observed at any NAVA level (figure 2). In 
PSV, phasic inspiratory EAta was observed in 2 of 8 lambs from PSV 10/4 upwards, in 2 
additional (total of 4) lambs from PSV 15/4 and in an additional lamb (total of 5) with 
PSV 20/4 (Table 2). In addition, in the 5 lambs with phasic inspiratory EAta during nPSV, 
%inspirEAta increased in proportion with PSV level (P = 0.02) (figure 5A). Regression 
analysis showed a positive relationship between the increase in %inspirEAta and 
ampliEAta (p = 0.008). Though not formally quantified, the presence of phasic 
inspiratory EAta in PSV was associated with a higher difference between Pmask and 
Ptrach (figure 6). Simultaneously, both %inspirEAct and ampliEAct dramatically 
decreased with application of CPAP 4, then virtually disappeared in 7 lambs with 
increasing nPSV (figure 5).  
 
Relationship between inspiratory glottal constrictor muscle activity and decrease 
in PCO2 during nPSV 
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In the 5 lambs with presence of phasic inspiratory EAta in nPSV, regression analysis 
showed a significant relationship between the decrease in PetCO2 or PaCO2 and the 
increase in %inspirEAta (p = 0.009 and p = 0.1, respectively). However, as shown in 
table 2, a decrease in PCO2 was neither necessary (lamb 7) nor sufficient (lamb 3) for 
the development of phasic inspiratory EAta in nPSV. In addition, the development of 
hypocapnia in nNAVA (lamb 6) was not accompanied by the development of phasic 
inspiratory EAta. 
 
15 
 
DISCUSSION 
 
This study demonstrates for the first time the effect of increasing nasal NAVA levels on 
laryngeal constrictor and dilator muscle activity in non-sedated, newborn lambs. In 
contrast to nasal pressure support ventilation, we observed that nasal NAVA does not 
induce active laryngeal constrictor inspiratory EMG in any lamb, even at maximal 
achievable NAVA level. In addition, our results show that hypocapnia is neither 
necessary nor sufficient for the development of active glottal closure with nasal pressure 
support ventilation. 
 
Thyroarytenoid and cricothyroid electrical activity during nPSV and nNAVA in 
quiet sleep  
The present study confirms that increasing the level of nasal PSV can induce phasic 
inspiratory EMG activity of a glottal constrictor muscle in lambs, whereas phasic 
inspiratory EMG activity of a glottal dilator muscle virtually disappears, in agreement with 
results from our 2 previous studies (24, 33). The qualitative observation of lower 
inspiratory Ptrach values compared to Pmask is also in agreement with our previously 
reported increase in inspiratory upper airway resistance when phasic inspiratory EAta is 
present during nIPPV (24) as well as with laryngoscopic observations in human adults of 
glottal narrowing when nIPPV level is increased (26). Of particular note, the present 
results confirm that inspiratory glottal narrowing can occur with clinically relevant, low 
level nPSV (10/4 cmH20) in some lambs (24). As alluded to in the introduction, such 
consequences of nPSV on upper airway resistance are important to know, as they could 
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contribute to difficulties in patient-ventilator interaction, as underlined in a recent review 
(30). Hence, by increasing laryngeal resistance, active glottal narrowing developing 
against ventilator insufflations could be responsible for oral leaks or complications 
related to diversion of insufflated air into the digestive system, which is of special 
concern in the newborn (16, 21). On the contrary, the total absence of any phasic 
inspiratory EAta during nNAVA, including at maximal achievable NAVA level, is 
noteworthy and clearly at variance with nPSV. The expected neural coordination 
between upper airway dilator muscles and diaphragm activity, where upper airway 
dilator activity precedes diaphragm activity (17), signifies that in nNAVA, the assist will 
always be delivered when the upper airways are open and “ready” to receive air 
insufflation from the ventilator. This may partly explain the better ventilator-patient 
interaction which has been recently reported in infants and children with nNAVA 
compared to nPSV (1, 38). 
 
Potential explanations for the absence of inspiratory glottal constrictor EMG in 
nNAVA and its presence in nPSV 
During nPSV, insufflation from the ventilator is performed with a constant level of 
pressure and time course set by the clinician, often with a short inspiratory rise-time in 
order to further decrease the patient’s inspiratory work (25). The consequent rapid 
airway pressurization at the onset of inspiration could be responsible for triggering, in a 
reflex manner, the inspiratory EMG activity of the glottal constrictor muscle, which 
originates from below the larynx (33). On the other hand, during nNAVA, the ventilator is 
driven by the respiratory centers, the amplitude and time course pattern of the 
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insufflation varying from breath to breath, closely following EAdi. In other words, under 
central drive, airway pressurization at onset of inspiration is always progressive in 
nNAVA, such that the pressure rise mimics the normal progressive recruitment of the 
diaphragmatic motor units (9). In this respect, future studies will undoubtedly need to 
question the importance of the inspiratory rise time in the development of inspiratory 
glottal constrictor muscle activity during nPSV. Of note, tidal volume in itself does not 
appear to be involved in the active glottal narrowing observed with nPSV. Indeed, 
despite a similar VT value (figure 4), phasic inspiratory EAta was present in half of the 
lambs at PSV 15/4 but in none of the lambs at NAVA max. Coupled with our previous 
results (33), this observation suggests that rapidly-adapting bronchopulmonary 
receptors, which are more sensitive to rapid change in pulmonary volume (6), are more 
likely to be responsible for inspiratory glottal narrowing than slowly-adapting 
bronchopulmonary receptors during nPSV. 
Enhancement of glottal constrictor muscle EMG activity by hypocapnia has been 
reported by several studies, especially during the post-inspiratory phase of the breathing 
cycle and during central apneas (18, 29, 39). Results from our previous studies however 
led us to hypothesize that the development of inspiratory EAta with increasing nIPPV 
was not related to a decrease in PCO2 (24). Results from the present study, where 
special care was taken to assess PCO2 variations more accurately, now suggest that the 
decrease in PCO2, at times down to true hypocapnia (< 35 mmHg), may bear some 
responsibility in the development of inspiratory EAta during nPSV. However, our results 
also show that a decrease in PCO2 is neither necessary nor sufficient for the 
development of inspiratory EAta during nIPPV. Overall, the present findings are in 
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agreement with previous suggestions that CO2 level is only partly responsible for glottal 
narrowing under nIPPV and that mechanical factors (pressure, flow) probably also 
influence glottal behavior (26). Future studies will be needed to further delineate the 
importance of PCO2 level in the development of inspiratory glottal constrictor muscle 
EMG during nPSV. 
 
In conclusion, the observation that nNAVA does not induce inspiratory glottal 
constrictor muscle activity in non-sedated newborn lambs, even at maximal achievable 
levels, appears as a further advantage compared to the widely used nPSV. While this 
can be of immediate clinical consequence for addressing inadequate patient-ventilator 
synchronization and the potential relevance of shifting from nPSV to nNAVA in such 
conditions, further studies are nevertheless necessary in order to explore the 
physiological reasons behind this clear difference brought about by nNAVA.  
19 
 
ACKNOWLEGMENTS 
 
The authors wish to fully acknowledge the excellent technical assistance of Norman 
Comtois and Jean-Philippe Gagné. This study was supported by the Canadian Institutes 
of Health Research (grant MOP 15558 allocated to JPP) and the Foundation of Stars. 
Jean-Paul Praud is the holder of the Canada Research Chair in Neonatal Respiratory 
Physiology and a member of the Centre de recherche clinique Étienne-Le Bel du Centre 
hospitalier universitaire de Sherbrooke. The Blom-Singer voice prostheses were 
graciously provided by InHealth Technologies, Carpinteria, CA, USA. 
 
Author contributions 
 
20 
 
REFERENCES 
 
1. Alander M, Peltoniemi O, Pokka T, Kontiokari T. Comparison of pressure-, flow-, 
and NAVA-Triggering in pediatric and neonatal ventilatory care. Pediatr Pulmonol In 
press, 2011 Aug 9. 
2. Aldrich T, Sinderby C, McKenzie D, Estenne M, Gandevia S. Electrophysiologic 
techniques for the assessment of respiratory muscle function. ATS/ERS Statement 
on Respiratory Muscle Testing. Am J Respir Crit Care Med 166: 518-624, 2002. 
3. Ali N, Claure N, Alegria X, D'Ugard C, Organero R, Bancalari E. Effects of non-
invasive pressure support ventilation (NI-PSV) on ventilation and respiratory effort in 
very low birth weight infants. Pediatr Pulmonol 42: 704-710, 2007. 
4. Allo JC, Beck J, Brander L, Brunet F, Slutsky AS, Sinderby CA. Influence of 
neurally adjusted ventilatory assist and positive end-expiratory pressure on 
breathing pattern in rabbits with acute lung injury. Crit Care Med 34: 2997–3004, 
2006. 
5. Andritsch RF, Muravchick S, Gold MI. Temperature correction of arterial blood-
gas parameters: A comparative review of methodology. Anesthesiology 55: 311-316, 
1981. 
6. Bailey EF, Fregosi RF. Modulation of upper airway muscle activities by 
bronchopulmonary afferents. J Appl Physiol 101: 609–617, 2006. 
21 
 
7. Barwing J, Ambold M, Linden N, Quintel M, Moerer O. Evaluation of the catheter 
positioning for neurally adjusted ventilatory assist. Intensive Care Med 35: 1809-
1814, 2009 
8. Beck J, Campoccia F, Allo JC, Brander L, Brunet F, Slutsky AS, Sinderby C. 
Improved synchrony and respiratory unloading by neurally adjusted ventilatory assist 
(NAVA) in lung-injured rabbits. Pediatr Res 61: 289–294, 2007. 
9. Beck J, Brander L, Slutsky AS, Reilly MC, Dunn MS, Sinderby C. Non-invasive 
neurally adjusted ventilatory assist in rabbits with acute lung injury. Intensive Care 
Med 34: 316-323, 2008. 
10. Beck J, Reilly M, Grasselli G, Mirabella L, Slutsky AS, Dunn MS, Sinderby C. 
Patient-ventilator interaction during neurally adjusted ventilatory assist in low birth 
weight infants. Pediatr Res 65: 663-668, 2009. 
11. Cammarota G, Olivieri C, Costa R, Vaschetto R, Colombo D, Turucz E, 
Longhini F, Della Corte F, Conti G, Navalesi P. Noninvasive ventilation through a 
helmet in postextubation hypoxemic patients: physiologic comparison between 
neurally adjusted ventilatory assist and pressure support ventilation. Intensive Care 
Med 37: 1943-50, 2011. 
12. Carreau AM, Patural H, Samson N, Doueik AA, Hamon J, Fortier PH, Praud JP. 
Effects of simulated reflux laryngitis on laryngeal chemoreflexes in newborn lambs. J 
Appl Physiol 111: 400-406, 2011. 
22 
 
13. Clement KC, Thurman TL, Holt SJ, Heulitt MJ. Neurally triggered breaths reduce 
trigger delay and improve ventilator response times in ventilated infants with 
bronchiolitis. Intensive Care Med 37: 1826-1832, 2011. 
14. Colombo D, Cammarota G, Bergamaschi V, De Lucia M, Corte FD, Navalesi P. 
Physiologic response to varying levels of pressure support and neurally adjusted 
ventilatory assist in patients with acute respiratory failure. Intensive Care Med 34: 
2010-2018, 2008. 
15. Diblasi RM. Nasal continuous positive airway pressure (CPAP) for the respiratory 
care of the newborn infant. Respir Care 54: 1209-1235, 2009. 
16. Garland JS, Nelson DB, Rice T, Neu J. Increased risk of gastrointestinal 
perforations in neonates mechanically ventilated with either face mask or nasal 
prongs. Pediatrics 76: 406-410, 1985. 
17. Kosch PC, Hutchinson AA, Wozniak JA, Carlo WA, Stark AR. Posterior 
cricoarytenoid and diaphragm activities during tidal breathing in neonates. J Appl 
Physiol 64: 1968-1978, 1988. 
18. Kuna ST, McCarthy MP, Smickley JS. Laryngeal response to passively induced 
hypocapnia during NREM sleep in normal adult humans. J Appl Physiol 75: 1088-
1096, 1993. 
19. Larrar S, Essouri S, Durand P, Chevret L, Haas V, Chabernaud JL, Leyronnas 
D, Devictor D. Effects of nasal continuous positive airway pressure ventilation in 
infants with severe acute bronchiolitis. Arch Pediatr 13: 1397-1403, 2006. 
23 
 
20. Lecomte F, Brander L, Jalde F, Beck J, Qui H, Elie C, Slutsky AS, Brunet F, 
Sinderby C. Physiological response to increasing levels of neurally adjusted 
ventilatory assist (NAVA). Respir Physiol Neurobiol 166: 117-124, 2009. 
21. Leone RJ Jr, Krasna IH. 'Spontaneous' neonatal gastric perforation: is it really 
spontaneous? J Pediatr Surg 35: 1066-1069, 2000. 
22. Létourneau P, Dumont S, Kianicka I, Diaz V, Dorion D, Drolet R, Praud JP. 
Radiotelemetry system for apnea study in lambs. Respir Physiol 116: 85-93, 1999. 
23. Mahmoud RA, Roehr CC, Schmalisch G. Current methods of non-invasive 
ventilatory support for neonates. Paediatr Respir Rev 12: 196-205, 2011. 
24. Moreau-Bussière F, Samson N, St-Hilaire M, Reix P, Lafond JR, Nsegbe E, 
Praud JP. Laryngeal response to nasal ventilation in nonsedated newborn lambs. J 
Appl Physiol 102: 2149-2157, 2007. 
25. Murata S, Yokoyama K, Sakamoto Y, Yamashita K, Oto J, Imanaka H, 
Nishimura M. Effects of inspiratory rise time on triggering work load during 
pressure-support ventilation: a lung model study. Respir Care 55: 878-884, 2010. 
26. Parreira VF, Jounieaux V, Aubert G, Dury M, Delguste PE, Rodenstein DO. 
Nasal two-level positive-pressure ventilation in normal subjects. Effects of the glottis 
and ventilation. Am J Respir Crit Care Med 153: 1616-1623, 1996. 
27. Piquilloud L, Vignaux L, Bialais E, Roeseler J, Sottiaux T, Laterre PF, Jolliet P, 
Tassaux D. Neurally adjusted ventilatory assist improves patient-ventilator 
interation. Intensive Care Med 37: 263-271, 2011. 
24 
 
28. Pneumatikos IA, Dragoumanis CK, Bouros DE. Ventilator-associated pneumonia 
or endotracheal tube-associated pneumonia? An approach to the pathogenesis and 
preventive strategies emphasizing the importance of endotracheal tube. 
Anesthesiology 110: 673–680, 2009. 
29. Praud JP, Canet E, Bureau MA. Chemoreceptor and vagal influences on 
thyroarytenoid muscle activity in awake lambs during hypoxia. J Appl Physiol 72: 
962-969, 1992. 
30. Rabec C, Rodenstein D, Leger P, Rouault S, Perrin C, Gonzalez-Bermejo J; 
SomnoNIV group. Ventilator modes and settings during non-invasive ventilation: 
effects on respiratory events and implications for their identification. Thorax 66: 170-
178, 2011. 
31. Ramanathan R. Nasal respiratory support through the nares: its time has come. J 
Perinatol 30 Suppl: S67-72, 2010. 
32. Renolleau S, Létourneau P, Niyonsenga T, Praud JP. Thyroarytenoid muscle 
electrical activity during spontaneous apneas in preterm lambs. Am J Respir Crit 
Care Med 159: 1396-1404, 1999. 
33. Roy B, Samson N, Moreau-Bussière F, Ouimet A, Dorion D, Mayer S, Praud JP. 
Mechanisms of active laryngeal closure during noninvasive intermittent positive 
pressure ventilation in nonsedated lambs. J Appl Physiol 105: 1406-1412, 2008. 
34. Samson N, St-Hilaire M, Nsegbe E, Reix P, Moreau-Bussière F, Praud JP. Effect 
of nasal continuous or intermittent positive airway pressure on nonnutritive 
swallowing in the newborn lamb. J Appl Physiol 99: 1636-1642, 2005. 
25 
 
35. Samson N, Lafond JR, Moreau-Bussière F, Reix P, Praud JP. Cricothyroid 
muscle electrical activity during respiration and apneas in lambs. Respir Physiol 
Neurobiol 155: 147-155, 2007. 
36. Sinderby C, Navalesi P, Beck J, Skrobik Y, Comtois N, Friberg S, Gottfried SB, 
Lindstrom L. Neural control of mechanical ventilation in respiratory failure. Nat Med 
5: 1433-1436, 1999. 
37. Spahija J, de Marchie M, Albert M, Bellemare P, Delisle S, Beck J, Sinderby C. 
Patient-ventilator interaction during pressure support ventilation and neurally 
adjusted ventilatory assist. Crit Care Med 38: 518-526, 2010 
38. Vignaux L, Grazioli S, Jaecklin T, Bochaton N, Piquilloud L, Tassaux D, Jolliet 
P, Rimensberger P. Patient-ventilator asynchrony during mechanical non-invasive 
assisted ventilation in children: preliminary results. Am J Respir Crit Care Med 183: 
A3191, 2011. 
39. Zhou D, Huang Q, St John WM, Bartlett D Jr. Respiratory activities of 
intralaryngeal branches of the recurrent laryngeal nerve. J Appl Physiol 67: 1171-
1178, 1989. 
 
26 
 
FIGURE LEGENDS 
 
Figure 1: Schematic representation of the experimental set-up in non-sedated, 
newborn lambs.  Ptrach: tracheal pressure; PetCO2: end tidal CO2 pressure; EcoG: 
electrocorticogram; EOG: electrooculogram; TA: thyroarytenoid muscle; CT: cricothyroid 
muscle; EMG: electrical muscle activity. 
 
Figure 2: Electrical activity (EA) of thyroarytenoid (ta, a glottal constrictor), cricothyroid 
(ct, a glottal dilator) and diaphragm (di) muscle during nasal pressure support ventilation 
(PSV) and neurally adjusted ventilatory assist (NAVA) during quiet sleep in one lamb. 
Contrary to NAVA max, PSV 20/4 triggers inspiratory EAta. Abbreviations: EAta: 
thyroarytenoid muscle EA; ∫EAta: moving time averaged EAta; EAct: cricothyroid muscle 
EMG; ∫EAct: moving time averaged EAct; EAdi: diaphragm EA; Pmask: mask pressure; 
Ptrach: tracheal pressure; Vlung: lung volume variations, given by the sum signal of 
respiratory inductance plethysmography (inspiration upwards); i: inspiration; e: 
expiration. 
 
Figure 3: Variations of mask Pressure (Pmask) during: A) PSV (10/4, 15/4 and 20/4 
cmH2O) and B) NAVA (NAVA 1, NAVA 2 and NAVA max) mode in one lamb. Contrary 
to PSV, breath-by-breath variations of Pmask were observed at all NAVA levels, 
reaching a highly irregular pattern at NAVA max. Such a high irregularity would not be 
appropriate in clinical practice, this level being assessed in the present experiment in 
order to study the highest possible peak inspiratory pressures in NAVA. 
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Figure 4: Variations of diaphragm energy expenditure and expiratory tidal volume (VT, 
ml/kg) during nasal pressure support ventilation (nPSV) and neurally adjusted ventilatory 
assist (nNAVA). 
Increasing the level of nPSV or nNAVA leads to a progressive decrease in the EAdi-time 
product (an indicator of diaphragm energy expenditure) (A) and a progressive increase 
in VT. Note the higher VT obtained with nPSV 20/4 vs. nNAVA max. Significant 
differences are indicated as *: vs. CPAP 4; †: vs. PSV 10/4; §: vs. PSV 15/4; ‡: vs. 
NAVA 1; #: vs. NAVA 2; ψ:  vs. NAVA max.  
 
Figure 5: Glottal constrictor (EAta) and dilator (EAct) muscle activity during the increase 
in nPSV and nNAVA. A) Percentage of ventilatory cycles with EAta (%inspirEAta) and 
amplitude of EAta (ampliEAta) are given for the 5 lambs with EAta in nPSV. AmpliEAta 
is given in percentage of maximal recorded EAta during recording (i.e., during a 
swallow) B) Percentage of ventilatory cycles with EAct (%inspirEAct) and amplitude of 
EAct (ampliEAct) are given for all 8 lambs. AmpliEAct is given in percentage of phasic 
inspiratory EAct recorded while on CPAP 0. 
 
Figure 6: Phasic inspiratory thyroarytenoid muscle activity limits pressure transmission 
to the lungs at PSV 20/4 (left panel), contrary to observations at NAVA max (right panel) 
in the same lamb. See figure 1 for abbreviations. Pressures are given in cmH2O.
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TABLES 
Table 1: Respiratory variables during nasal pressure support ventilation and Neurally Adjusted Ventilatory Assist 
Values are reported as mean (standard deviation). RR: ventilator respiratory rate. Pmask: mask pressure; Ptrach: tracheal 
pressure; PIP: peak inspiratory pressure; PEEP: positive end-expiratory pressure; PaO2: arterial O2 pressure; PaCO2: 
arterial CO2 pressure;  PetCO2: end tidal CO2 pressure; HCO3-: serum bicarbonates. EAdi-time product: diaphragmatic 
energy expenditure index.  n = 8 lambs, except for PaO2, PaCO2, HCO3-, pH (7 lambs). Underlined exponent: p < 0.05; 
normal font exponent: p < 0.1. a: vs. PSV 10/4; b: vs. PSV 15/4; c: vs. PSV 20/4; d: vs. NAVA 1; e: vs. NAVA 2; f: vs. 
NAVA max. 
 Baseline Pressure Support: PIP/PEEP (cmH2O) NAVA: Gain level 
 No CPAP CPAP 4 10/4 15/4 20/4 NAVA 1 NAVA 2 NAVA max 
RRvent (breaths/min) 41 (10.5) 36.5 (8.5) b c e f 34 (8)  b c 28 (7.5) c 20.5 (4) 32 (7.12) e f 26.5 (5.24) 22.5 (5.5) 
Pmask (cm H2O) 0.1 (0.0) 7.1 (1.3) 11.5 (0.8) 16 (0.8) 21 (0.5) 11 (0.5) 14.5 (1.5) 17.5 (1.5) 
Ptrach (cm H2O) 1 (1) 6 (0.5) 10 (0.5) 14.5 (1) 18.5 (2) 10 (1) 14 (2) 16 (1.5) 
PaO2 (mmHg) 84 (12.5) 94 (10.5) c 93.5 (8) c 96.5 (9.5) c 106 (17) 100 (14) 101.5 (20) 96 (8.5) 
PaCO2 (mmHg) 46 (5) 44.5 (5) c 44 (7.5) c 43 (8) c 34.5 (6.5) f 44.5 (5.5) 45 (7.5) 43.5 (9) 
PetCO2  (mmHg) 51.5 (4.5) 52 (3.5) b c f 50.5 (3.5) b c 46.5 (4) c 40.5 (7.5) f 51 (4.5) 50 (4.5) 48 (6) 
pH 7.37 (0.07) 7.38 (0.07) c 7.38 (0.04) b c 7.4 (0.08) c 7.47 (0.15) f 7.37 (0.06) 7.37 (0.07) f 7.39 (0.08) 
HCO3- (mmol/l) 26 (4.5) 26 (5) 26 (7.5) 26 (6.5) 24.5 (5) 25.5 (5) 26 (6) 26 (7) 
EAdi-time product (au.s.min-1) 299.8 (76) 225.9 (132) b c d 185.1 (130) b 107.8 (67) 125.4 (62) f 279.1 (119) e f 225.3 (91) f 195.3 (67) 
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Tableau 2: Percentage of respiratory cycles with inspiratory phasic activity of the thyroarytenoid muscle and 
PaCO2 during nasal pressure support ventilation or neurally adjusted ventilatory assist (NAVA) in 
lambs during quiet sleep  
 Nasal Pressure Support Ventilation Nasal NAVA 
 10/4 15/4 20/4 NAVA 1 NAVA 2 NAVA max 
 %inspirEAta PaCO2 %inspirEAta PaCO2 %inspirEAta PaCO2 %inspirEAta PaCO2 %inspirEAta PaCO2 %inspirEAta PaCO2 
lamb 1 0 - 44 - 100 - 0 - 0 - 0 - 
lamb 2 51 40.5 57 40.5 100 36 0 41.5 0 46 0 41.5 
lamb 3 0 53.5 0 50 0 30.5 0 51.5 0 52.5 0 45 
lamb 4 0  38 0 43.5 0 38 0 42 0 45,5 0 40 
lamb 5 17 55 30 50.5 22 26.5 0 50.5 0 53.5 0 60 
lamb 6 0 35 33 30 62 29 0 38 0 35 0 31 
lamb 7 0 40.5 0 36.5 100 39.5 0 39.5 0 35.5 0 39.5 
lamb 8 0 45.5 0 49 0 44.5 0 49 0 46.5 0 46 
%inspirEAta: percentage of ventilatory cycles with EAta. 
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